BioForce Nanosciences 报告亏损，在财务困境中其股价跌至 0.56 美元。 BioForce Nanosciences reports a loss, seeing its stock drop to $0.56 amid financial struggles.

据生物力量纳米科学社报告,本季度的每股收入损失为0.01美元,其股票价格在星期二下降0.01美元至0.56美元。 BioForce Nanosciences reported a $0.01 earnings loss per share for the quarter, with its stock price dropping $0.01 to $0.56 on Tuesday. 该公司价值1 871万美元,专门从事通过零售商、超市和在线销售的天然维生素和补充剂。 The company, valued at $18.71 million, specializes in natural vitamins and supplements sold through retailers, supermarkets, and online. 其负P/E比率为-55.80,反映了其最近的损失。 Its negative P/E ratio of -55.80 reflects its recent loss.